Meta description: A not yet recruiting trial evaluates transcranial direct current stimulation for social media craving, with regulatory implications for device makers and investors.
In regulatory news dated February 15, 2026 a ClinicalTrials.gov record lists a not yet recruiting trial evaluating a brain stimulation device for social media addiction and related cravings. The study identifies conditions including Social Media Addiction craving to use social media craving Internet Addiction and uses two intervention arms: active Transcranial Direct Current Stimulation tDCS and Sham Transcranial Direct Current Stimulation Sham tDCS. Sponsor is Egas Moniz Cooperativa de Ensino Superior CRL. The trial record number is NCT07410104. The link to the public record is provided in the article and no study results are reported yet.
What is being studied?
The record covers conditions including Social Media Addiction craving to use social media craving Internet Addiction. The intervention uses two device arms active tDCS and Sham tDCS. The trial targets people who report craving related to social media use and related internet use patterns. No claims about efficacy are stated in the record and results are not yet available.
How is the trial designed and what is tested?
Participants and design
The entry identifies two arms that compare an active tDCS device with a sham control. The format and dosing are not described in the excerpt provided, and no results are reported yet. The device is described as a Transcranial Direct Current Stimulation system used for noninvasive brain stimulation with a sham option to blind participants.
Device description and safety considerations
The record provides a regulatory level description of a device intended to modulate neural activity to influence craving related to social media use. Safety and performance data are not included in the summary and would appear in later trial documentation in line with regulatory practice for brain stimulation devices.
Regulatory context and responsibilities
The sponsor listed is Egas Moniz Cooperativa de Ensino Superior CRL. The status is not yet recruiting. The trial is registered on ClinicalTrials.gov with the identifier NCT07410104. This report relies on the public record; no trial results are available at this time. The entry illustrates ongoing use of brain stimulation devices for behavioral conditions and highlights regulatory considerations for device makers seeking to evaluate new indications.
Timeline and next steps
Because recruitment has not started, timelines for enrollment and completion are not provided in the record. Future steps depend on regulatory review outcomes and study approvals by the sponsor and participating sites. Observers should monitor the ClinicalTrials.gov page for updates on recruitment status and posted results.
Sponsor and status implications
The trial is funded by Egas Moniz Cooperativa de Ensino Superior CRL. Not yet recruiting status signals that the study is in early phases of site setup and protocol finalization. Updates on the ClinicalTrials.gov record should be watched for changes in recruitment status or protocol amendments.
FAQ
- What is tDCS and what does sham tDCS mean in this study?
- Who is sponsoring the trial and where is it conducted?
- What conditions are included in the study?
- Where can I view the public trial record?
Conclusion and implications for readers
This entry signals regulatory interest in using direct current stimulation to address craving in digital behaviors. No results are available yet. Regulators and device developers should assess how this aligns with MDR expectations and how future data may inform safe indications.
Disclaimer for professionals
This article is informational and not legal advice. It summarizes a public trial record and does not provide regulatory guidance.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07410104?term=medical+device